Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction

SJ Greene, GC Fonarow - European Heart Journal, 2023 - academic.oup.com
Conclusion Although the totality of scientific evidence supports sacubitril/valsartan as having
incremental efficacy over valsartan in a broad population of patients with HF and EF> 40 …
被引用次数：3 相关文章

[引用][C] Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction

SJ Greene, GC Fonarow - European heart journal - pubmed.ncbi.nlm.nih.gov

[引用][C] Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction.

SJ Greene, GC Fonarow - European Heart Journal, 2023 - europepmc.org
Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction.
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction

SJ Greene, GC Fonarow - European Heart Journal, 2023 - academic.oup.com
Conclusion Although the totality of scientific evidence supports sacubitril/valsartan as having
incremental efficacy over valsartan in a broad population of patients with HF and EF> 40 …